Timothy Coughlin is Director at Travere Therapeutics, Inc. (TVTX). They have made 2 open-market trades across 2 companies since 2022, most recently 2026-06-12.
1 open-market purchase totalling $88K since 2024, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-06-12 | 2026-06-16 | $50.07 | $501K | +8.8% | +3.2% | +22.8% |
| TVTX | SELL · 10b5-1 | 2026-05-15 | 2026-05-19 | $43.49 | $141K | +6.7% | +30.5% | +50.4% |
| TVTX | SELL · 10b5-1 | 2025-10-31 | 2025-11-04 | $35.03 | $631K | +1.5% | +3.9% | -2.7% |
| LIFE | BUY | 2024-05-30 | 2024-06-03 | $1.75 | $88K | +587.6% | +805.9% | +805.9% |
| FATE | SELL | 2022-06-03 | 2022-06-06 | $22.81 | $33K | -10.4% | +32.5% | +17.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.